JPMORGAN CHASE & CO - ADAMAS PHARMACEUTICALS INC ownership

ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 117 filers reported holding ADAMAS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.28 and the average weighting 0.3%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of ADAMAS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$0280.0%0.00%
Q2 2021$0280.0%0.00%
Q1 2021$0
-100.0%
28
-99.9%
0.00%
Q4 2020$205,000
+23.5%
47,366
+17.7%
0.00%
Q3 2020$166,000
-45.0%
40,235
-65.9%
0.00%
Q2 2020$302,000
-31.8%
117,954
-23.0%
0.00%
Q1 2020$443,000
+1065.8%
153,188
+1444.9%
0.00%
Q4 2019$38,0000.0%9,916
+34.0%
0.00%
Q3 2019$38,000
+2.7%
7,402
+19.3%
0.00%
Q2 2019$37,000
-5.1%
6,202
+14.2%
0.00%
Q1 2019$39,000
-20.4%
5,429
-4.5%
0.00%
Q4 2018$49,000
-52.0%
5,684
+11.7%
0.00%
Q3 2018$102,000
-97.5%
5,088
-96.8%
0.00%
-100.0%
Q2 2018$4,095,000
-29.6%
158,537
-34.8%
0.00%0.0%
Q1 2018$5,814,000
-35.4%
243,286
-8.4%
0.00%
-50.0%
Q4 2017$9,006,000
+217.2%
265,739
+95.0%
0.00%
+100.0%
Q3 2017$2,839,000
+15672.2%
136,273
+13028.4%
0.00%
Q2 2017$18,000
-99.3%
1,038
-99.3%
0.00%
-100.0%
Q1 2017$2,691,000
-11.7%
153,763
-14.8%
0.00%0.0%
Q4 2016$3,049,000
+13.6%
180,384
+10.4%
0.00%0.0%
Q3 2016$2,683,000
+13.8%
163,450
+4.9%
0.00%0.0%
Q2 2016$2,358,000
+42.9%
155,799
+36.5%
0.00%
Q1 2016$1,650,000
+6.0%
114,106
+107.5%
0.00%
Q4 2015$1,557,000
+50.7%
54,981
-10.9%
0.00%
Q3 2015$1,033,000
-34.8%
61,728
+2.2%
0.00%
Q2 2015$1,584,000
+36.0%
60,389
-9.3%
0.00%
Q1 2015$1,165,000
-4.4%
66,600
-5.0%
0.00%
Q4 2014$1,218,000
+422.7%
70,100
+460.8%
0.00%
Q3 2014$233,000
-72.6%
12,500
-73.2%
0.00%
Q2 2014$851,00046,5600.00%
Other shareholders

There were no reported owners of ADAMAS PHARMACEUTICALS INC in Q4 2017.

NameSharesValueWeighting ↓
View complete list of ADAMAS PHARMACEUTICALS INC shareholders